Prospective Cohort Study Quantifying the Effect of the Levalap 1.0 ™ on the Distance between the Abdominal Wall and Intra-Abdominal Víscera

Over 13 million laparoscopic procedures are performed globally every year. The LevaLap 1.0 ™ device may facilitate safe abdominal access when using the Veress needle for initial abdominal insufflation during laparoscopic surgery. We undertook this study to test the hypothesis that use of the LevaLap 1.0™ would increase the distance from the abdominal wall to underlying viscera and the retroperitoneum, including from major vessels.

Source: The Journal of Minimally Invasive Gynecology - October 27, 2023 Category: OBGYN Authors: F Orsi, D Maietttini, V Bagnardi, R Azziz Tags: ORAL SESSION 05 - Laparoscopy Source Type: research